The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 174.00
Bid: 171.50
Ask: 174.00
Change: -2.50 (-1.42%)
Spread: 2.50 (1.458%)
Open: 179.00
High: 179.00
Low: 173.00
Prev. Close: 176.50
TTG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collaboration on COVID-19 screening device

1 Sep 2020 07:00

RNS Number : 5414X
TT Electronics PLC
01 September 2020
 

 

 

1 September 2020

TT Electronics plc

 

Collaboration on COVID-19 screening device

 

TT Electronics plc ("TT") notes the recent media coverage in relation to trials of Virolens®, a non-clinical COVID-19 screening device, at Heathrow airport.

TT has been working with iAbra, the creator of Virolens®, and its partners University of Bristol, Dell and Intel, to design, develop and test the prototype Virolens® screening device and to specify and design the manufacturing processes.

TT has also been appointed exclusive manufacturing partner for the commercial launch of Virolens®. Revenues from Virolens® are dependent on iAbra's end customers converting expressions of interest into firm orders, and subject to Virolens® meeting further regulatory authority requirements.

 

For further information please contact:

 

 

TT Electronics plc

Tel: +44 (0)1932 827 779

Richard Tyson, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Julian Wais, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Rachel Mann

 

 

   

About TT Electronics

 

TT Electronics is a global provider of engineered electronics for performance-critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers primarily in aerospace and defence, medical and industrial sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities including in the UK, US, Mexico, Sweden and Asia.

The company has three divisions. The Power and Connectivity division designs and manufactures power application products and connectivity devices which enable the capture and wireless transfer of data. We collaborate with our customers to develop innovative solutions to optimise their electronic systems. The Global Manufacturing Solutions division provides manufacturing services and engineering solutions for our product divisions and to customers that often require a lower volume and higher mix of products. We manufacture complex integrated product assemblies for our customers and provide engineering services including designing testing solutions and value-engineering. The Sensors and Specialist Components division works with customers to develop standard and customised solutions including sensors and power management devices. Our solutions improve the precision, speed and reliability of critical aspects of our customers' applications.

 

 

Cautionary statement

This announcement contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPBMITMTAJBPM
Date   Source Headline
9th Apr 20247:00 amRNSCapital Markets Event
4th Apr 20245:40 pmRNSAnnual Financial Report
2nd Apr 20247:00 amRNSCompletion of Divestment
19th Mar 20244:44 pmRNSLong Term Incentive Plan
19th Mar 20248:15 amRNSNon-Executive Director Change
15th Mar 20248:30 amRNSDeferred Share Bonus Plan
12th Mar 20249:01 amRNSDeferred Share Bonus Plan
12th Mar 20249:00 amRNSLong Term Incentive Plan
7th Mar 20247:00 amRNSFull Year Results
4th Mar 20247:00 amRNSDivestment of selected business units
1st Mar 20242:25 pmRNSTotal Voting Rights
15th Feb 20243:59 pmRNSTotal Voting Rights
26th Jan 20248:54 amRNSHolding(s) in Company
25th Jan 202411:32 amRNSHolding(s) in Company
22nd Jan 20244:53 pmRNSHolding(s) in Company
3rd Jan 202411:24 amRNSTotal Voting Rights
4th Dec 20239:02 amRNSTotal Voting Rights
24th Nov 202310:36 amRNSDirectorate Change
22nd Nov 20237:00 amRNSTrading Update
15th Nov 20238:36 amRNSBlock Listing Application
3rd Nov 20232:48 pmRNSHolding(s) in Company
30th Oct 20234:45 pmRNSBlock Listing Six Monthly Return
25th Oct 20238:33 amRNSHolding(s) in Company
11th Oct 20238:40 amRNSHolding(s) in Company
2nd Oct 20232:40 pmRNSShare Awards for Incoming Chief Executive Officer
2nd Oct 20238:27 amRNSHolding(s) in Company
1st Sep 202311:00 amRNSDirector Declaration
1st Sep 202310:58 amRNSTotal Voting Rights
25th Aug 20238:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNSHalf-year Results
27th Jul 20237:00 amRNSCEO Appointment
27th Jun 20235:35 pmRNSHolding(s) in Company
15th Jun 20232:32 pmRNSHolding(s) in Company
13th Jun 20234:11 pmRNSHolding(s) in Company
1st Jun 20235:06 pmRNSTotal Voting Rights
10th May 20233:12 pmRNSBoard Committee Change
10th May 202311:14 amRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 202311:12 amRNSBlock listing six monthly return
24th Apr 20233:18 pmRNSHolding(s) in Company
17th Apr 20239:21 amRNSHolding(s) in Company
13th Apr 20237:00 amRNSBoard Change
6th Apr 20234:33 pmRNSHolding(s) in Company
6th Apr 20237:46 amRNSHolding(s) in Company
5th Apr 20235:46 pmRNSDirector/PDMR Shareholding
5th Apr 20233:48 pmRNSAnnual Financial Report
31st Mar 20231:25 pmRNSHolding(s) in Company
28th Mar 20233:59 pmRNSDirector/PDMR Shareholding
20th Mar 202311:28 amRNSLong Term Incentive Plan
20th Mar 202311:25 amRNSDeferred Share Bonus Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.